Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Alopecia Areata might be linked to Crohn's disease.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Hair cortisol levels peak in the third trimester and decline postpartum.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.